Craft
Akouos

Akouos

Total Funding

$162.5 M

Akouos Summary

Company summary

Overview
Akouos is a company that develops targeted gene therapies designed to treat hearing disorders. Its therapies restore and preserve hearing in genetically-defined patient populations from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling patients to hear properly and getting the functional proteins required for hearing.
Type
Private
Founded
2017
HQ
Boston, MA, US | view all locations
Website
https://akouos.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Manny Simons

    Manny Simons, Founder and CEO

    • Michael McKenna

      Michael McKenna, Chief Medical Officer & Co-Founder

      • John Connelly, Senior Vice President, Portfolio Strategy and R&D Operations

        • Greg Robinson

          Greg Robinson, Chief Scientific Officer

          LocationsView all

          1 location detected

          • Boston, MA HQ

            United States

            645 Summer St #200

          Footer menu